155 related articles for article (PubMed ID: 24993157)
1. Minding the gaps in tuberculosis research.
Ekins S; Nuermberger EL; Freundlich JS
Drug Discov Today; 2014 Sep; 19(9):1279-82. PubMed ID: 24993157
[No Abstract] [Full Text] [Related]
2. Mycobacterium tuberculosis High-Throughput Screening.
White EL; Tower NA; Rasmussen L
Methods Mol Biol; 2016; 1439():181-95. PubMed ID: 27316996
[TBL] [Abstract][Full Text] [Related]
3. [Phage amplified biologically assay and its application in rapid detection of Mycobacterium tuberculosis].
Hu ZY
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Dec; 27(12):850-2. PubMed ID: 15730788
[No Abstract] [Full Text] [Related]
4. Tuberculosis drug resistance: summary report for 2003.
Can Commun Dis Rep; 2004 May; 30(10):93-5. PubMed ID: 15174496
[No Abstract] [Full Text] [Related]
5. Tuberculosis drug resistance in an area of low endemicity in 2004 to 2006: semiquantitative drug susceptibility testing and genotyping.
Springer B; Calligaris-Maibach RC; Ritter C; Böttger EC
J Clin Microbiol; 2008 Dec; 46(12):4064-7. PubMed ID: 18923010
[TBL] [Abstract][Full Text] [Related]
6. Minimising moxifloxacin resistance with tuberculosis.
Drlica K; Zhao X; Kreiswirth B
Lancet Infect Dis; 2008 May; 8(5):273-5. PubMed ID: 18471768
[No Abstract] [Full Text] [Related]
7. [Primary resistance of Mycobacterium tuberculosis].
Barranquero Arola M; Gorritxo Gil B; Goiriena de Gandarias J
Rev Sanid Hig Publica (Madr); 1984; 58(11-12):1107-15. PubMed ID: 6443589
[No Abstract] [Full Text] [Related]
8. Mycobacterium tuberculosis: drug resistance and future perspectives.
Riccardi G; Pasca MR; Buroni S
Future Microbiol; 2009 Jun; 4(5):597-614. PubMed ID: 19492969
[TBL] [Abstract][Full Text] [Related]
9. Isoniazid activity is terminated by bacterial persistence.
Mitchison DA; Jindani A; Davies GR; Sirgel F
J Infect Dis; 2007 Jun; 195(12):1871-2; author reply 1872-3. PubMed ID: 17492605
[No Abstract] [Full Text] [Related]
10. Persistence, not resistance, is the cause of loss of isoniazid effect.
Wallis RS; Palaci M; Eisenach K
J Infect Dis; 2007 Jun; 195(12):1870-1; author reply 1872-3. PubMed ID: 17492604
[No Abstract] [Full Text] [Related]
11. First- and second-line antituberculosis drug resistance patterns among previous treatment failure patients in Myanmar.
Nyunt WW; Aung ST; Lwin T; Cook GM; Aung HL
J Glob Antimicrob Resist; 2017 Jun; 9():34-35. PubMed ID: 28323227
[No Abstract] [Full Text] [Related]
12. Wild-type distributions of seven oral second-line drugs against Mycobacterium tuberculosis.
Schön T; Juréen P; Chryssanthou E; Giske CG; Sturegård E; Kahlmeter G; Hoffner S; Angeby KA
Int J Tuberc Lung Dis; 2011 Apr; 15(4):502-9. PubMed ID: 21396210
[TBL] [Abstract][Full Text] [Related]
13. Microbiology. TB--a new target, a new drug.
Cole ST; Alzari PM
Science; 2005 Jan; 307(5707):214-5. PubMed ID: 15653490
[No Abstract] [Full Text] [Related]
14. [Anti-tuberculosis drugs].
Doi N
Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():367-74. PubMed ID: 17455647
[No Abstract] [Full Text] [Related]
15. [Resistance to antitubercular drugs in strains of Mycobacterium tuberculosis isolated in Spain].
Ausina Ruiz V; Lonca Giménez J
Rev Clin Esp; 1999 Mar; 199(3):121-5. PubMed ID: 10230288
[No Abstract] [Full Text] [Related]
16. [Prevalence of primary drug resistance in M. tuberculosis in four administrative areas of the North-Western Federal District of the Russian Federation].
Baranov AA; Mar'iandyshev AO; Nizovtseva NI; Oparina EN; Presnova SE; Gvozdovskaia LA; Markelov IuM; Trekin IA; Tungusova OS; Mannsoker T
Probl Tuberk Bolezn Legk; 2006; (12):9-12. PubMed ID: 17300065
[TBL] [Abstract][Full Text] [Related]
17. Current challenges in drug discovery for tuberculosis.
Kumar A; Chettiar S; Parish T
Expert Opin Drug Discov; 2017 Jan; 12(1):1-4. PubMed ID: 27797593
[No Abstract] [Full Text] [Related]
18. [Signal transduction and drug resistance in Mycobacterium tuberculosis--A review].
Wang S; Feng Y; Zhang Z
Wei Sheng Wu Xue Bao; 2015 Aug; 55(8):971-6. PubMed ID: 26665593
[TBL] [Abstract][Full Text] [Related]
19. Drugs versus bugs: in pursuit of the persistent predator Mycobacterium tuberculosis.
Sacchettini JC; Rubin EJ; Freundlich JS
Nat Rev Microbiol; 2008 Jan; 6(1):41-52. PubMed ID: 18079742
[TBL] [Abstract][Full Text] [Related]
20. Detection of and treatment protocol for rifampicin-monoresistant tuberculosis: what is the role of isoniazid?
Velayati AA; Farnia P; Masjedi MR; Hoffner S
Int J Tuberc Lung Dis; 2013 Jun; 17(6):849-50. PubMed ID: 23676176
[No Abstract] [Full Text] [Related]
[Next] [New Search]
